CClinicalTrials.gg
CompletedNCT02297893Updated Aug 31, 2016

Improving Dexterous Skills in Parkinson's Disease

An interventional study of Dexterity training program (HOMEDEXT) and Theraband training program in Parkinson Disease, sponsored by Luzerner Kantonsspital. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-08-31.

Sponsored by Luzerner Kantonsspital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
103
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Background and aim: Patients with Parkinson's disease (PD) exhibit disturbed manual dexterity. This impairment leads to difficulties in activities of daily living (ADL) such as buttoning a T-shirt or hand-writing. The aim of the present research project is to investigate the effectiveness of a high intensity home based exercise intervention focusing on fine motor skills (HOMEDEXT), in patients with PD.

Design: A single blinded randomized controlled trial (RCT) will be performed. Randomization will be done by an independent biostatistician who will use a computerized randomization protocol. A baseline assessment and a follow-up measurement 4 weeks immediately after intervention (end of rehabilitation) will be performed. A follow-up measurement, 12 weeks later, will be done to assess long-lasting effects. Assessments will be performed by investigators who are blinded for the intervention.

Participants: One hundred and four out-patients with PD will be recruited who report specific difficulties in manual dexterity when executing ADL. Intervention: The patients will be allocated to either an intervention group (n = 52) or control group (n = 52). In the intervention group PD patients will exercise, over a period of four weeks, once/day during 30 minutes a treatment with specific exercises for dexterity. The PD patients, who will be allocated to the control group, will exercise Theraband exercises.

Outcome measures: The primary outcome measures for manual dexterity will be the Nine Hole Peg test. Secondary outcome measures will be the Coin Rotation task, a sensitive screening for dexterity. Furthermore for ADL a modified version of the subscale II of the Movement Disorders Society unified Parkinson's Disease Rating Scale (MDS-UPDRS) will be used. Parkinsonian symptoms will be assessed by the MDS-UPDRS subscale III. To assess improvements in quality of life a modified version of the Parkinson's Disease Questionnaire (PDQ-39) will be used.

Read the detailed description

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects both motor and non-motor basal ganglia circuitry (Stern et al., 2012). The degeneration of dopaminergic neurons in the substantia nigra leads to the clinical manifestation of the cardinal motor features of PD: bradykinesia, muscle rigidity, tremor at rest and impairment of postural reflexes (Bohlhalter \& Kägi, 2011). While dopaminergic therapy improves some symptoms of PD, other symptoms, such as impaired finger dexterity, may be less responsive to pharmacological treatment (Quencer et al., 2007; Gebhardt et al., 2008). Patients with PD often report difficulties in activities of daily living (ADL), such as fastening T-shirt buttons or tying shoe laces, activities which require dexterous skills (Peto et al., 2001; Nijkrake et al., 2009). The exact mechanisms for the loss in finger dexterity are not known. Elementary motor deficits such as bradykinesia (Agostino et al., 2003), reduced strength and finger torque production (Fellows et al., 1998; de Oliveira et al., 2008) certainly play a role. However, these deficits do not fully account for the motor impairment and it has been suggested that an apraxic disorder called limb kinetic apraxia, may significantly contribute to the dexterous deficits observed in PD (Quencer et al., 2007; Gebhardt et al. 2008; Vanbellingen et al., 2011, 2012).

Only limited data exist on therapeutic interventions of dexterous problems in PD (Dixon et al., 2007; Rao, 2010). However, there is increasing evidence that allied health care, which includes physical therapy (PT), speech-language therapy and occupational therapy (OT), may complement the standard pharmacological and surgical treatments (Van der Marck et al., 2009). These therapies aim to minimize the impact of the disease process, and improve the patient's participation in ADL. Two major treatment approaches are most commonly used for PD: movement strategy training and muskuloskeletal exercises (Morris et al., 2009). By using movement strategies, patients with PD may bypass the defective basal ganglia, by engaging alternative neural circuits that are still intact (frontal and parietal cortical pathways). Examples are mental rehearsing and focusing attention (Morris et al., 2009) or using sensory cues to initiate and maintain movements (Nieuwboer et al. 2007). However, a disadvantage of this treatment approaches, particularly the recruitment of frontal cortex, is its dependence on preserved cognitive abilities. As the disease progress, many patients with PD eventually develop cognitive impairments (Aarsland et al., 2010), which could negatively influence the learning of movement strategies (Nieuwboer et al., 2009). Musculoskeletal exercises aim to improve strength, joint range of movement, muscle length and endurance (Trend et al. 2002). High intensity exercise programs have been successful and showed either short or long-term effects for balance and gait for patients with PD (Hirsch et al., 2003; Morris et al., 2009; Ebersbach et al., 2010), of which most training modes were consistent with principles promoting activity-dependent neuroplasticity (Petzinger et al. 2010). Activity-dependent neuroplasticity is defined as the modifications within the central nervous system, in response to physical activity that promotes a skill acquisition process (Adkins et al., 2006). As such intensity, specificity, difficulty; and complexity of practice appear to be important parameters for driving neuroplasticity and a potential lasting effect on both brain and behavior (Petzinger et al. 2010). In contrast to the significant short and long-term improvements which were found after high intensity training for gait and balance (Hirsch et al., 2003; Morris et al., 2009; Ebersbach et al., 2010), there is little evidence for fine motor skills in patients with PD (Gauthier et al., 1987). However, no well-designed study has been conducted, so far, which focused on these aspects of motor skills in PD.

Until date no well designed trial has been performed, in patients with PD, to investigate whether a high intensity exercise program, focusing on fine motor skills, could improve dexterous skills. As described above, patients with PD often experience impaired dexterity which leads to significant disability in several ADL, contributing to a reduced quality of life. For gait and balance disorders, high intensity training programs have been shown to be successful in patients with PD, based on training modes driving activity-dependent plasticity. However, the question remains open whether a high intensity exercise program, focusing on fine motor skills, could be effective as well in patients with PD.

The aims of the present project are to assess the outcomes of a high intensity exercise intervention, focusing on fine motor skills, in in-patients with PD. The short and long-term benefits of this training program will be compared with conventional training, which patients already receive during their hospital stay. For this purposes, a single blinded randomized controlled trial (RCT) will be performed.

Based on the literature we hypothesize that the specific home based dexterity program (HOMEDEXT) will improve fine motor skills both at short term and long-term, detected by the primary outcome measurement nine-hole peg test (Earhart et al. 2011). The improved finger and hand functions will also lead to improved ADL functioning as assessed by a modified version of the subscale II of the Movement Disorders Society unified Parkinson's Disease Rating Scale (MDS-UPDRS) (Goetz et al., 2008). Furthermore, we expect that patients with PD will report a higher quality of life (QoL), as assessed by the secondary outcome measures, a modified version of the Parkinson's Disease Questionnaire (PDQ-39) (Peto et al., 2001).

02

Conditions studied

  • Parkinson Disease

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 103 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Luzerner Kantonsspital is the lead sponsor of 60 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients will be included if they fulfill the criteria defined by the UK Parkinson's Disease Society Brain Bank Criteria (Hughes et al. 1992), with Hoehn and Yahr stages II to IV.

Exclusion criteria

Exclusion Criteria:

  • Significant medical, psychiatric co-morbidity including dementia as defined by Montreal Cognitive Assessment (MOCA) (Gill et al. 2008)
  • Patients who received OT in the last 12 months to avoid carryover effects
  • Inability to complete questionnaires (i.e. due to cognitive problems)
  • Participation in another intervention trial
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
103 participants (actual)

Study arms

  • Experimental
    Dexterity training program (HOMEDEXT)

    This program is a a high intensity training program adapted from a previously published arm ability training program

    Behavioral: Dexterity training program (HOMEDEXT)

  • Active comparator
    Theraband training program

    7 different Theraband exercises. Total duration is 30 minutes, trained 5 times a week over a period of 4 weeks

    Behavioral: Theraband training program

Interventions

  • BehavioralDexterity training program (HOMEDEXT)

    The dexterity training program contains 7 exercises which focus on improving fine motor skills.

  • BehavioralTheraband training program

    The Theraband training program contains 7 exercises which focus on improving upper limb strength

06

What researchers measure

Primary outcomes

  1. Nine Hole Peg Test

    Time frame: 2 minutes

Secondary outcomes

  1. Coin Rotation task

    Time frame: 4 weeks

  2. Modified MDS-UPDRS scale II

    Time frame: 4 weeks

  3. PDQ-39

    Time frame: 4 weeks

  4. Dexterity Questionnaire

    Time frame: 4 weeks

07

Study locations

1 site
  • Luzerner Kantonsspital
    Luzern, 6000, Switzerland
08

References and documents

Publications

  • Vanbellingen T, Kersten B, Bellion M, Temperli P, Baronti F, Muri R, Bohlhalter S. Impaired finger dexterity in Parkinson's disease is associated with praxis function. Brain Cogn. 2011 Oct;77(1):48-52. doi: 10.1016/j.bandc.2011.06.003. Epub 2011 Jul 19. PubMed 21775040 ↗
  • Bohlhalter S. [Update on parkinson disease]. Rev Med Suisse. 2013 Jan 30;9(371):247-8. No abstract available. German. PubMed 23451586 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02297893
Lead sponsor
Luzerner Kantonsspital
Responsible party
Tim Vanbellingen (Dr. phil., Luzerner Kantonsspital) — Principal investigator
First posted
Nov 21, 2014
Start date
Nov 2014
Primary completion
Aug 2016
Completion
Aug 2016
Last update
Aug 31, 2016

Study contacts

René Müri, MD
study chair · University of Bern

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion